TY  - JOUR
AU  - Nyssen, Olga P
AU  - Perez-Aisa, Angeles
AU  - Castro-Fernandez, Manuel
AU  - Pellicano, Rinaldo
AU  - Huguet, Jose M
AU  - Rodrigo, Luis
AU  - Ortuñ, Juan
AU  - O,
AU  - Gomez-Rodriguez, Blas J
AU  - Pinto, Ricardo M
AU  - Areia, Miguel
AU  - Perona, Monica
AU  - Nuñez, Oscar
AU  - Romano, Marco
AU  - Gravina, Antonietta G
AU  - Pozzati, Liliana
AU  - Fernandez-Bermejo, Miguel
AU  - Venerito, Marino
AU  - Malfertheiner, Peter
AU  - Fernanadez-Salazar, Luis
AU  - Gasbarrini, Antonio
AU  - Vaira, Dino
AU  - Puig, Ignasi
AU  - Megraud, Francis
AU  - O'Morain, Colm
AU  - Gisbert, Javier P
AU  - Hp-EuReg investigators
PY  - 2021
DO  - 10.1177/2050640620972615
UR  - http://hdl.handle.net/10668/16588
T2  - United European gastroenterology journal
AB  - There has been resurgence in the use of bismuth quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) for treating Helicobacter pylori infection thanks to a three-in-one single-capsule formulation. To evaluate the...
LA  - en
KW  - Helicobacter pylori
KW  - Pylera
KW  - bismuth
KW  - eradication
KW  - quadruple
KW  - Adolescent
KW  - Adult
KW  - Anti-Bacterial Agents
KW  - Bismuth
KW  - Capsules
KW  - Drug Combinations
KW  - Drug Resistance, Bacterial
KW  - Europe
KW  - Female
KW  - Gastrointestinal Diseases
KW  - Helicobacter Infections
KW  - Helicobacter pylori
KW  - Humans
KW  - Intention to Treat Analysis
KW  - Male
KW  - Medication Adherence
KW  - Metronidazole
KW  - Middle Aged
KW  - Proton Pump Inhibitors
KW  - Registries
KW  - Tetracycline
KW  - Young Adult
TI  - European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice.
TY  - research article
VL  - 9
ER  -